Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

There is mounting evidence implicating cytokines such as interleukin-1 in the local regulation of bone homeostasis. In this report we show that recombinant human interleukin-1 beta (rhIL-1 beta) influences several activities of osteoblast-like cells derived from human trabecular bone explants in vitro. rhIL-1 beta stimulated cellular proliferation and the synthesis of prostaglandin E2 and plasminogen activator activity in the cultured human osteoblast-like cells in a dose-dependent manner. However, the induction of osteocalcin synthesis and alkaline phosphatase activity in response to 1,25(OH)2D3, two characteristics of the osteoblast phenotype, were antagonized by rhIL-1 beta over a similar dose range. This study adds further support to the potential role of interleukin-1 in the physiological and pathological modulation of bone cell metabolism.

Original publication

DOI

10.1016/0006-291x(90)91932-i

Type

Journal article

Journal

Biochem biophys res commun

Publication Date

15/01/1990

Volume

166

Pages

208 - 216

Keywords

Alkaline Phosphatase, Bone and Bones, Calcitriol, Cell Division, Cells, Cultured, Dinoprostone, Dose-Response Relationship, Drug, Humans, Interleukin-1, Kinetics, Osteoblasts, Osteocalcin, Plasminogen Activators, Recombinant Proteins